Post-earnings recap
Reported
Wed, May 1, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
Dexcom's earnings report shows a mixed picture, with a narrower-than-expected loss on EPS but no revenue figures available. The stock fell by 2.02% in response, likely due to the lack of revenue data and guidance. Investors may be concerned about the company's ability to meet future expectations without clear financial targets.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.05 | N/A | +30.50% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a sense of cautious optimism about future growth. They emphasized their commitment to innovation and market expansion.
Management expressed confidence in future product launches.
They highlighted ongoing investments in innovation.
There was a focus on expanding market reach despite current challenges.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—